Safety of intravitreal pegcetacoplan inpatients with neovascular age-related macular degeneration receiving anti-VEGF therapy

被引：0

作者：

Hu, Allen ^{[1
]}

Esmaili, Daniel ^{[2
]}

Ribiero, Ramiro ^{[3
]}

Bliss, Caleb ^{[3
]}

Jones, Daniel ^{[3
]}

Brown, David ^{[4
]}

机构：

[1] Meritus Med Ctr, Hagerstown, MD USA

[2] Retina Vitreous Associates Med Grp, Los Angeles, CA USA

[3] Apellis Pharmaceut Inc, Waltham, MA USA

[4] Retina Consultants Texas, Houston, TX USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2021年 / 62卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

427

引用

页数：2

共 50 条

[41] Maintenance of Vision Needed to Drive after Intravitreal Anti-VEGF Therapy in Patients with Neovascular Age-related Macular Degeneration and Diabetic Macular Edema [J].

Emami-Naeini, Parisa ;

Garmo, Vincent ;

Boucher, Nick ;

Fernando, Rusirini ;

Menezes, Alicia .

OPHTHALMOLOGY RETINA, 2024, 8 (04) :388-398

[42] Dexamethasone intravitreal implant combined with anti-VEGF in patients with neovascular age related macular degeneration resistant to anti-VEGF alone [J].

Ricci, G. Deamico ;

Giancipoli, E. ;

Boscia, F. ;

Zasa, G. ;

Sotgiu, G. ;

Dore, G. ;

Pinna, A. .

ACTA OPHTHALMOLOGICA, 2017, 95

[43] Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration [J].

Arai, Yusuke ;

Takahashi, Hidenori ;

Inoda, Satoru ;

Tan, Xue ;

Sakamoto, Shinichi ;

Inoue, Yuji ;

Fujino, Yujiro ;

Kawashima, Hidetoshi ;

Yanagi, Yasuo .

PLOS ONE, 2020, 15 (03)

[44] Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy [J].

Reiter, Gregor S. ;

Schmidt-Erfurth, Ursula .

THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2022, 14

[45] Macular Atrophy in Patients with Neovascular Age Related Macular Degeneration Undergoing Anti-VEGF Therapy [J].

Abdelfattah, Nizar Saleh ;

Zhang, Hongyang ;

Boyer, David S. ;

Sadda, Srinivas R. .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)

[46] Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration [J].

Schmidt-Erfurth, Ursula ;

Vogl, Wolf-Dieter ;

Jampol, Lee Merrill ;

Bogunovic, Hrvoje .

OPHTHALMOLOGY, 2020, 127 (09) :1211-1219

[47] Parameters Influencing Clinical Decision Making in Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration [J].

Seidman, Carly ;

Yeung, Keel ;

Tseng, Joseph J. ;

Wald, Kenneth J. .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)

[48] Specific alterations in the retinal microstructure in neovascular age-related macular degeneration under anti-VEGF therapy [J].

Schneiderbauer, T. ;

Ahlers, C. ;

Stock, G. ;

Golbaz, I. ;

Schuetze, C. ;

Sacu, S. ;

Schmidt-Erfurth, U. .

OPHTHALMOLOGE, 2011, 108 (01) :38-+

[49] Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy [J].

Prea, Selwyn M. ;

Chan, Elsa C. ;

Dusting, Gregory J. ;

Vingrys, Algis J. ;

Bui, Bang V. ;

Liu, Guei-Sheung .

JOURNAL OF OPHTHALMOLOGY, 2015, 2015

[50] Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update [J].

Parravano, Mariacristina ;

Costanzo, Eliana ;

Scondotto, Giulia ;

Trifiro, Gianluca ;

Virgili, Gianni .

BIODRUGS, 2021, 35 (06) :673-692

← 1 2 3 4 5 →